Pro-Inflammatory Markers in Serum and Saliva in Periodontitis and Hypertension
- PMID: 40572711
- PMCID: PMC12194881
- DOI: 10.3390/medicina61061024
Pro-Inflammatory Markers in Serum and Saliva in Periodontitis and Hypertension
Abstract
Background and Objectives: Over the past few decades, a substantial body of evidence has linked periodontitis to systemic diseases-including hypertension-but the mechanisms underlying this association are not fully understood. This study aims to identify the factors that may mediate this relationship, including an analysis of the inflammatory biomarker NLRP3 and IL-1β levels in serum and saliva in patients with both diseases. Materials and Methods: This study included 108 individuals (mean age, 47.8 years, SD 12.8), 38.9% male and 61.1% female. The participants were divided into four groups: Group I-26 healthy participants; Group II-24 participants with periodontitis; Group III-26 participants with hypertension; and Group IV-32 participants with both periodontitis and hypertension. Clinical examinations were performed to diagnose hypertension and periodontitis, including a survey and blood tests in all patients. NLRP3 and IL-1β levels in serum and saliva were measured using ELISA. Results: Patients with periodontitis and hypertension were significantly older than those without these conditions (respectively, p < 0.001 and p < 0.001) and had more missing teeth (respectively, p < 0.001 and p = 0.037). Higher values were found in the periodontitis and hypertension group than in healthy individuals for VLDL (p = 0.001), triglycerides (p = 0.001), CRP (p = 0.003), WBC (p = 0.007), blood sugar (p = 0.002), total cholesterol (p = 0.003), and LDL (p = 0.010). Significantly higher levels of NLRP3 in saliva (p = 0.038) and serum (p = 0.021) were observed in patients with periodontitis than in those without periodontitis. Significant correlations were found between serum NLRP3 levels and the presence of hypertension (p = 0.001) and between saliva IL-1β levels and the presence of hypertension (p = 0.010). Serum NLRP3 levels demonstrated a predictive value for hypertension (AUC 0.693, 95% CI 0.590-0.796, and p = 0.001), with an established cutoff value of 0.68 ng/mL (sensitivity 0.623, specificity 0.630). Conclusions: The higher levels and correlations of pro-inflammatory markers in serum and saliva observed in patients with periodontitis and hypertension support the hypothesis of a relationship between these diseases, likely mediated by low-grade systemic inflammation.
Keywords: IL1-β; NLRP3; hypertension; periodontitis.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
[Application of combined detection of inflammatory indexes and cytokines in chronic periodontitis].Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Aug 18;57(4):772-778. doi: 10.19723/j.issn.1671-167X.2025.04.023. Beijing Da Xue Xue Bao Yi Xue Ban. 2025. PMID: 40754918 Free PMC article. Chinese.
-
A minimally Invasive Biomarker for Sensitive and Accurate Diagnosis of Parkinson's Disease.medRxiv [Preprint]. 2024 Jun 30:2024.06.29.24309703. doi: 10.1101/2024.06.29.24309703. medRxiv. 2024. Update in: Acta Neuropathol Commun. 2024 Oct 22;12(1):167. doi: 10.1186/s40478-024-01873-1. PMID: 38978648 Free PMC article. Updated. Preprint.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450. Health Technol Assess. 2007. PMID: 17999840
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
References
-
- Arregoces F.M.E., Roa N.S., Velosa-Porras J., Rodríguez L.V., Merchan M.J., Poveda J.C.V., Otero L., Ruiz Á.J., Uriza C.L. Changes in Serum Inflammatory Markers and in Clinical Periodontal Condition After Non-Surgical Periodontal Treatment in Hypertensive Patients. Biomedicines. 2025;13:374. doi: 10.3390/biomedicines13020374. - DOI - PMC - PubMed
-
- Papapanou P.N., Sanz M., Buduneli N., Dietrich T., Feres M., Fine D.H., Flemmig T.F., Garcia R., Giannobile W.V., Graziani F., et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Periodontol. 2018;89((Suppl. S1)):S173–S182. doi: 10.1002/JPER.17-0721. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous